Traws Pharma, Inc.

Public companies file this within four business days when something important happens that investors should know about before the next quarterly report.

Traws Pharma, Inc. filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. 1 Traws Pharma Provides Regulatory Update on Influenza Program NEWTOWN, PA — June 12, 2026 — (GLOBENEWSWIRE) Traws Pharma, Inc. (NASDAQ: TRAW, the Company), a clinical-stage biopharmaceutical company developing novel therapies for critical global viral threats, today announced that the planned test of tivoxavir marboxil (TXM) in a Phase 2a human…